P1028Acute myocarditis with suppressed cardiac function is associated with a high risk of sudden cardiac death in the early phase that can be prevented by the wearable cardioverter defibrillator

2018 ◽  
Vol 39 (suppl_1) ◽  
Author(s):  
A Marx ◽  
H Mollnau ◽  
S Sonnenschein ◽  
P Wenzel ◽  
T Muenzel ◽  
...  
Keyword(s):  
High Risk ◽  
Sudden Cardiac Death ◽  
Cardiac Function ◽  
Early Phase ◽  
Cardiac Death ◽  
Cardioverter Defibrillator ◽  
Wearable Cardioverter Defibrillator

scholarly journals Usefulness of the Wearable Cardioverter-Defibrillator in Patients at High Risk for Sudden Cardiac Death

2014 ◽  
Vol 78 (12) ◽  
pp. 2987-2989 ◽  
Author(s):  
Shingo Sasaki ◽  
Hirofumi Tomita ◽  
Shuji Shibutani ◽  
Kei Izumiyama ◽  
Takumi Higuma ◽  
...  
Keyword(s):  
High Risk ◽  
Sudden Cardiac Death ◽  
Cardiac Death ◽  
Cardioverter Defibrillator ◽  
Wearable Cardioverter Defibrillator

scholarly journals Experience With the Wearable Cardioverter-Defibrillator in Patients at High Risk for Sudden Cardiac Death

Circulation ◽  
2016 ◽  
Vol 134 (9) ◽  
pp. 635-643 ◽  
Author(s):  
Nadine K. Wäßnig ◽  
Michael Günther ◽  
Silvio Quick ◽  
Christian Pfluecke ◽  
Fabian Rottstädt ◽  
...  
Keyword(s):  
High Risk ◽  
Sudden Cardiac Death ◽  
Cardiac Death ◽  
Cardioverter Defibrillator ◽  
Wearable Cardioverter Defibrillator

Secondary prevention of sudden cardiac death in ischaemic cardiomyopathy

ESC CardioMed ◽  
2018 ◽  
pp. 2337-2341
Author(s):  
Jens Cosedis Nielsen ◽  
Jens Kristensen
Keyword(s):  
Heart Failure ◽  
Cardiac Arrest ◽  
Heart Disease ◽  
High Risk ◽  
Sudden Cardiac Death ◽  
Secondary Prevention ◽  
Cardiac Death ◽  
Cardioverter Defibrillator ◽  
Ischaemic Cardiomyopathy ◽  
Life Threatening

The most common reason for sudden cardiac death is ischaemic heart disease. Patients who survive cardiac arrest are at particularly high risk of recurrent ventricular arrhythmia and sudden cardiac death, and are candidates for secondary prevention defined as ‘therapies to reduce the risk of sudden cardiac death in patients who have already experienced an aborted cardiac arrest or life-threatening arrhythmias’. The mainstay therapy for secondary prevention of sudden cardiac death is implantation of an implantable cardioverter defibrillator. Furthermore, revascularization and optimal medical therapy for heart failure and concurrent cardiovascular diseases should be ensured.

scholarly journals Wearable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death

2019 ◽  
Vol 5 (2) ◽  
pp. 152-161 ◽  
Author(s):  
Ahmad Masri ◽  
Ahmed M. Altibi ◽  
Sebhat Erqou ◽  
Mohammad A. Zmaili ◽  
Ala Saleh ◽  
...  
Keyword(s):  
Sudden Cardiac Death ◽  
Cardiac Death ◽  
Cardioverter Defibrillator ◽  
Wearable Cardioverter Defibrillator
Sign in / Sign up

Export Citation Format

Share Document